Merck Serono Supports India’s Two-tier Drug Pricing Policy

Thursday, February 13, 2014

Merck Serono, whose pharmaceutical roots go back to 1668, has not only become the latest global giant to support lower pricing for emerging markets but has also opposed incremental innovation — a favourite bugbear of the Indian government and local industry.

Source: The Economic Times (link opens in a new window)

Education, Health Care
research, supply chains